The low C5 convertase activity of the C4A6 allotype of human complement component C4
- PMID: 2803239
- PMCID: PMC1138894
- DOI: 10.1042/bj2610743
The low C5 convertase activity of the C4A6 allotype of human complement component C4
Abstract
We have compared the C5-convertase-forming ability of different C4 allotypes, including the C4A6 allotype, which has low haemolytic activity and which has previously been shown to be defective in C5-convertase formation. Recent studies suggest that C4 plays two roles in the formation of the C5 convertase from the C3 convertase. Firstly, C4b acts as the binding site for C3 which, upon cleavage by C2, forms a covalent linkage with the C4b. Secondly, C4b with covalently attached C3b serves to form a high-affinity binding site for C5. Purified allotypes C4A3, C4B1 and C4A6 were used to compare these two activities of C4. Covalently linked C4b-C3b complexes were formed on sheep erythrocytes with similar efficiency by using C4A3 and C4B1, indicating that the two isotypes behave similarly as acceptors for covalent attachment of C3b. C4A6 showed normal efficiency in this function. However, cells bearing C4b-C3b complexes made from C4A6 contained only a small number of high-affinity binding sites for C5. Therefore a lack of binding of C5 to the C4b C3b complexes is the reason for the inefficient formation of C5 convertase by C4A6. The small number of high-affinity binding sites created, when C4A6 was used, were tested for inhibition by anti-C3 and anti-C4. Anti-C4 did not inhibit C5 binding, whereas anti-C3 did. This suggests that the sites created when C4A6 is used to make C3 convertase may be C3b-C3b dimers, and hence the low haemolytic activity of C4A6 results from the creation of low numbers of alternative-pathway C5-convertase sites.
Similar articles
-
A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.J Immunol. 1992 May 1;148(9):2803-11. J Immunol. 1992. PMID: 1573269
-
Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.J Exp Med. 1987 Jun 1;165(6):1494-507. doi: 10.1084/jem.165.6.1494. J Exp Med. 1987. PMID: 3495629 Free PMC article.
-
Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.J Biol Chem. 1990 Aug 25;265(24):14444-9. J Biol Chem. 1990. PMID: 2387864
-
Structure/function of C5 convertases of complement.Int Immunopharmacol. 2001 Mar;1(3):415-22. doi: 10.1016/s1567-5769(00)00039-4. Int Immunopharmacol. 2001. PMID: 11367526 Review.
-
C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.Year Immunol. 1989;4:218-30. Year Immunol. 1989. PMID: 2648703 Review. No abstract available.
Cited by
-
Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE).Clin Exp Immunol. 1992 Mar;87(3):410-4. doi: 10.1111/j.1365-2249.1992.tb03011.x. Clin Exp Immunol. 1992. PMID: 1347491 Free PMC article.
-
Mutants of complement component C3 cleaved by the C4-specific C1-s protease.Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8125-9. doi: 10.1073/pnas.89.17.8125. Proc Natl Acad Sci U S A. 1992. PMID: 1518837 Free PMC article.
-
Study of hydraulic cutting as a method to prevent coal burst disasters.Heliyon. 2024 May 3;10(10):e30679. doi: 10.1016/j.heliyon.2024.e30679. eCollection 2024 May 30. Heliyon. 2024. PMID: 38765037 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous